Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Francois Schiele,
Francois Schiele (France)
Presentation webcastPresentation slides
List of Authors: François Schiele, Frédéric Capuano, Philippe Loirat, Armelle Desplanques-Leperre, Geneviève Derumeaux, Jean-François Thebaut, Christine Gardel
Aims: In Acute Myocardial Infarction (AMI), the relationship between volume and Quality Indicators (QI) is poorly documented. Through a nationwide assessment of QI at discharge repeated for three years, we aimed to quantify the relationship between volume and QIs in survivors after AMI. Methods: Almost all healthcare organisations in France participated. Medical records were randomly selected. Data collection was performed by a independent group. QIs for AMI were defined by an expert consensus group as appropriate prescription at discharge of aspirin, clopidogrel, beta-blocker, statin and an ACE inhibitor in patients with left ventricular ejection fraction <0.40. A composite QI was calculated using the “all or none” method. Volume was classed in 7 categories based on the number of admissions for AMI in 2008 (centres with <10 AMI were excluded). Odds Ratios (ORs) adjusted for age and gender with 95% CI for volume categories were calculated using logistic regression for each QI. Temporal changes were tested in centres who participated in all three campaigns. Results: A total of 48,503 records were examined: 18,159 in 2008, 14,027 in 2009 and 16,317 in 2010. Median centre volume was 90. 291 centres were eligible for the temporal analysis. AP of antiplatelet agents, beta-blockers, ACEI and statins at discharge increased significantly between 2008 and 2009, and between 2009 and 2010 for AP of ACEI, beta-blockers, statins and the composite QI. Compared to a volume of >300, a significantly lower rate of all QIs was observed in centres with the lowest volume. ORs progressively decreased with increasing volume, but reached a plateau above a threshold of 120 AMI hospitalisations per year. Despite a significant increase in the composite QI over the 3 years, a significant relation persisted between volume (±90) and quality of care. Conclusion: Analysis of QIs at discharge demonstrates the existence of a relation between volume and quality of care. Centres with the highest volume perform better on quality measures than centres with lower volumes. Temporal analysis over 3 consecutive years confirms this relation and shows that it persists despite improvement in quality indicators between 2008 and 2010.
Clinical Registry Highlight I - Risk and treatment reality